» Articles » PMID: 9075924

The T Cell Activation Factor NF-ATc Positively Regulates HIV-1 Replication and Gene Expression in T Cells

Overview
Journal Immunity
Publisher Cell Press
Date 1997 Mar 1
PMID 9075924
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical deterioration in human immunodeficiency virus type 1 (HIV-1) infection is associated with increased levels of viral replication and burden in the peripheral blood and lymphoid organs. T cell activation and ensuing cellular gene activation can be critical for HIV-1 replication. The hypothesis that the nuclear factor of activated T cells (NF-AT) may influence HIV-1 replication is therefore compelling given the tight correlation of HIV-1 transcriptional induction to T cell activation. We report that certain NF-AT(Rel) family members productively bind the kappaB regulatory elements, synergize with NF-kappaB and Tat in transcriptional activation of HIV-1, and enhance HIV-1 replication in T cells. These results link regulatory factors critical to T cell commitment directly to HIV-1 replication.

Citing Articles

The cell biology of HIV-1 latency and rebound.

Mbonye U, Karn J Retrovirology. 2024; 21(1):6.

PMID: 38580979 PMC: 10996279. DOI: 10.1186/s12977-024-00639-w.


The Ca-dependent phosphatase calcineurin dephosphorylates TBK1 to suppress antiviral innate immunity.

Qu Y, Wang S, Jiang H, Wang Q, Liao Y, Qiu X J Virol. 2024; 98(5):e0001624.

PMID: 38563732 PMC: 11092360. DOI: 10.1128/jvi.00016-24.


HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies.

Hyder U, Shukla A, Challa A, DOrso I Viruses. 2024; 16(2).

PMID: 38400062 PMC: 10892460. DOI: 10.3390/v16020287.


New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care.

Hokello J, Tyagi K, Owor R, Sharma A, Bhushan A, Daniel R Life (Basel). 2024; 14(1).

PMID: 38255719 PMC: 10817636. DOI: 10.3390/life14010104.


The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.

McMyn N, Varriale J, Fray E, Zitzmann C, MacLeod H, Lai J J Clin Invest. 2023; 133(17).

PMID: 37463049 PMC: 10471168. DOI: 10.1172/JCI171554.